Seeking Alpha

MissionIR's  Instablog

MissionIR
Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
MissionIR
My blog:
MissionIR Blog
  • AxoGen, Inc. (AXGN) Makes Initial Commercial Shipment Of Avance Nerve Graft To Distributor In Italy 0 comments
    Jul 16, 2012 3:29 PM | about stocks: AXGN

    AxoGen is a regenerative medicine company focused on the development and commercialization of products and technologies for peripheral nerve reconstruction and regeneration. Peripheral nerves are very important as they provide the pathways for both motor and sensory signals throughout the body.

    The company's portfolio of peripheral nerve-related products includes the Avance Nerve Graft, a allograft nerve for bridging nerve discontinuities (gaps created when nerves are severed) of 5-70 millimeters in length. By eliminating a second surgery to harvest the patient's own nerve tissue for use in the repair, the Avance Nerve Graft offers a viable alternative to traditional nerve repair procedures.

    The company's portfolio also includes the AxoGuard Nerve Connector, a coaptation aid allowing for close approximation of severed nerves, and the AxoGuard Nerve Protector, a bioscaffold used to reinforce a coaptation site, wrap a partially severed nerve, or isolate and protect nerve tissue.

    AxoGen announced today approval for its first commercial shipment by the Rizzoli Orthopedic Institute of the Avance Nerve Graft to its new distributor partner in Italy, MD for Life. The Rizzoli Orthopedic Institute is Italy's largest tissue bank and handles review and approval of all donors of AxoGen processed nerve allograft tissue to assure quality. The company's CEO, Karen Zaderej, spoke optimisticly about the shipment, "[It] confirms the growing demand for Avance Nerve Graft in markets outside of the United States."

    For additional information about AxoGen and its portfolio of nerve-related products, please visit the company's website at www.axogeninc.com

    Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

    Stocks: AXGN
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.